This query appears to be a misunderstanding or a misspelling. Tzield is a medication, not a phone. It is used to delay the onset of stage 3 type 1 diabetes in individuals aged 2 years and older who have stage 2 type 1 diabetes [1].
What is Tzield?
Tzield (teplizumab-mzwv) is an immunosuppressive drug that works by binding to CD3 on T lymphocytes. This binding is thought to modify T-cell activity, leading to a preservation of beta-cell function in the pancreas. It is administered intravenously [1].
Who manufactures Tzield?
Tzield is manufactured by Provention Bio [2].
How is Tzield administered?
Tzield is given as a single 30-minute intravenous infusion every four weeks for a total of 12 infusions [1].
What is the indication for Tzield?
Tzield is indicated to delay the onset of stage 3 type 1 diabetes in individuals aged 2 years and older who have stage 2 type 1 diabetes [1].
What are the risks associated with Tzield?
The most common serious adverse reactions observed in clinical trials included a decrease in the number of lymphocytes and a rash. Patients receiving Tzield are also at an increased risk for adverse reactions, including hypersensitivity reactions, and may have a reduced ability to fight infections [1]. Healthcare providers should monitor patients for signs and symptoms of serious adverse reactions.
What is the clinical trial data for Tzield?
The efficacy of Tzield was established in a randomized, placebo-controlled trial in individuals with stage 2 type 1 diabetes. The trial demonstrated that Tzield delayed the onset of stage 3 type 1 diabetes compared to placebo [1].
What is type 1 diabetes?
Type 1 diabetes is an autoimmune disease where the body's immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. This leads to a deficiency in insulin, a hormone essential for regulating blood sugar levels [3].
What are the stages of type 1 diabetes?
Type 1 diabetes is generally classified into three stages:
* Stage 1: Characterized by the presence of autoantibodies but no symptoms or elevated blood glucose levels.
* Stage 2: Autoantibodies are present, and individuals begin to experience dysglycemia (impaired glucose metabolism) but have not yet met the diagnostic criteria for stage 3.
* Stage 3: Full-blown type 1 diabetes, diagnosed by symptoms and persistently elevated blood glucose levels due to significant beta-cell destruction [1].
Can Tzield cure type 1 diabetes?
Tzield is not a cure for type 1 diabetes; it is indicated to delay the onset of stage 3 disease [1].
---
Sources:
[1] DrugPatentWatch.com - Tzield Information
[2] Provention Bio - Company Information
[3] American Diabetes Association - Type 1 Diabetes Overview